Carcinogenesis, Vol. 20, No. 9, 1837-1844,
September 1999
© 1999 Oxford University Press
Carcinogenesis |
A multihit, multistage model of chemical carcinogenesis
Molecular and Cellular Toxicology, Department of Toxicology, North Carolina State University, Raleigh, NC 27695-7633 and
1 Laboratory for Cancer Research, Rutgers University, Piscataway, NJ 08855, USA
Carcinogenesis involves the accumulation of genetic changes within a single cell. Tumor promotion functions in the initial clonal expansion of an initiated cell but is generally not considered to influence later stages. To investigate whether tumor promotion can influence later stages of carcinogenesis we developed a two-hit 7,12-dimethylbenz[a]anthracene (D) protocol designed to enrich for keratinocytes that contain at least two D-induced genetic alterations. FVB/N mice were initiated with D and promoted with 12-O-tetradecanoylphorbol-13-acetate (T) or treated with acetone (A) vehicle for 6 weeks. At 7 weeks after the start of promotion, but before visible papilloma development, groups of mice were treated with a second dose of D or A and 1 week later T promotion was resumed. D/T/A/T mice developed 2.8 papillomas/mouse and D/A/D/T mice demonstrated an additive tumor response and developed 5.8 papillomas/mouse. Importantly, D/T/D/T mice developed 12.4 papillomas/mouse, thereby demonstrating a synergistic tumor response compared with D/A/D/T and D/T/A/T mice. D/T/D/T papillomas exhibited increases in suprabasal S phase cells and keratin 13 expression when compared with D/T/A/T papillomas. D/T/D/T mice developed squamous cell carcinomas (SCCs) 10 weeks earlier than D/T/A/T mice and demonstrated a 96% malignancy incidence and 1.71 SCC/mouse compared with D/T/A/T mice, which demonstrated a 28% malignancy incidence and 0.32 SCC/mouse. Greater than 90% of D/T/A/T and D/T/D/T papillomas and SCCs contained mutant Ha-ras, while a normal Ha-ras allele persisted in all cases, indicating that a gene other than the remaining normal allele of Ha-ras was a target gene for the second D hit. These data demonstrate that: (i) promotion between the first and second hits has a profound outcome on carcinogenesis, presumably by increasing the probability that a second hit will occur in a previously initiated cell; (ii) continued promotion after the second hit is required for full expression of malignancy; (iii) the classic initiation–promotion protocol can be extended to a multihit, multistage model.
Abbreviations: A, acetone; BrdU, 5-bromo-2'-deoxyuridine; D, 7,12-dimethylbenz[a]anthracene; MNNG, N-methyl-N'-nitro-N-nitroguanidine; SCC, squamous cell carcinoma; SSCP, single-strand conformation polymorphism; SURF, selective UV radiation fractionation; T, 12-O-tetradecanoylphorbol-13-acetate.
2 Present address: Imperial Cancer Research Fund, Keratinocyte Laboratory, London WC2A 3PX, UK
3 To whom correspondence should be addressed Email: rcsmart{at}unity.ncsu.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Fung, P. Liu, and B. Demple ATF4-Dependent Oxidative Induction of the DNA Repair Enzyme Ape1 Counteracts Arsenite Cytotoxicity and Suppresses Arsenite-Mediated Mutagenesis Mol. Cell. Biol., December 15, 2007; 27(24): 8834 - 8847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Sadun, S. M. Sachsman, X. Chen, K. W. Christenson, W. Z. Morris, P. Hu, and A. L. Epstein Immune Signatures of Murine and Human Cancers Reveal Unique Mechanisms of Tumor Escape and New Targets for Cancer Immunotherapy Clin. Cancer Res., July 1, 2007; 13(13): 4016 - 4025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Roberts, B. Y. Ng, R. B. Filler, J. Lewis, E. J. Glusac, A. C. Hayday, R. E. Tigelaar, and M. Girardi Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis PNAS, April 17, 2007; 104(16): 6770 - 6775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.A. Crallan, N.T. Georgopoulos, and J. Southgate Experimental models of human bladder carcinogenesis Carcinogenesis, March 1, 2006; 27(3): 374 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Niemann, D. M. Owens, J. Hulsken, W. Birchmeier, and F. M. Watt Expression of {Delta}NLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours Development, January 1, 2002; 129(1): 95 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Owens and F. M. Watt Influence of {beta}1 Integrins on Epidermal Squamous Cell Carcinoma Formation in a Transgenic Mouse Model: {{alpha}}3{beta}1, but not {{alpha}}2{beta}1, Suppresses Malignant Conversion Cancer Res., July 1, 2001; 61(13): 5248 - 5254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Girardi, D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday Regulation of Cutaneous Malignancy by gamma delta T Cells Science, October 19, 2001; 294(5542): 605 - 609. [Abstract] [Full Text] [PDF]
|
|